C9ORF72 repeat expansions in cases with previously identified pathogenic mutations

Marka Van Blitterswijk, Matthew C. Baker, Mariely Hernandez, Roberta Ghidoni, Luisa Benussi, Elizabeth Finger, Ging Yuek R Hsiung, Brendan J. Kelley, Melissa E Murray, Nicola J. Rutherford, Patricia E. Brown, Thomas Ravenscroft, Bianca Mullen, Peter E A Ash, Kevin F. Bieniek, Kimmo J. Hatanpaa, Anna Karydas, Elisabeth McCarty Wood, Giovanni Coppola, Eileen H. BigioCarol Lippa, Michael J. Strong, Thomas G. Beach, David S Knopman, Edward D. Huey, Marsel Mesulam, Thomas Bird, Charles L. White, Andrew Kertesz, Dan H. Geschwind, Vivianna M. Van Deerlin, Ronald Carl Petersen, Giuliano Binetti, Bruce L. Miller, Leonard Petrucelli, Zbigniew K Wszolek, Kevin B. Boylan, Neill R Graff Radford, Ian R. MacKenzie, Bradley F Boeve, Dennis W Dickson, Rosa V Rademakers

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Objective: To identify potential genetic modifiers contributing to the phenotypic variability that is detected in patients with repeat expansions in chromosome 9 open reading frame 72 (C9ORF72), we investigated the frequency of these expansions in a cohort of 334 subjects previously found to carry mutations in genes known to be associated with a spectrum of neurodegenerative diseases. Methods: A 2-step protocol, with a fluorescent PCR and a repeat-primed PCR, was used to determine the presence of hexanucleotide expansions in C9ORF72. For one double mutant, we performed Southern blots to assess expansion sizes, and immunohistochemistry to characterize neuropathology. Results: We detected C9ORF72 repeat expansions in 4 of 334 subjects (1.2% [or 1.8% of 217 families]). All these subjects had behavioral phenotypes and also harbored well-known pathogenic mutations in either progranulin (GRN: p.C466LfsX46, p.R493X, p.C31LfsX35) or microtubule-associated protein tau (MAPT: p.P301L). Southern blotting of one double mutant with a p.C466LfsX46 GRN mutation demonstrated a long repeat expansion in brain (>3,000 repeats), and immunohistochemistry showed mixed neuropathology with characteristics of both C9ORF72 expansions and GRN mutations. Conclusions: Our findings indicate that co-occurrence of 2 evidently pathogenic mutations could contribute to the pleiotropy that is detected in patients with C9ORF72 repeat expansions. These findings suggest that patients with known mutations should not be excluded from further studies, and that genetic counselors should be aware of this phenomenon when advising patients and their family members.

Original languageEnglish (US)
Pages (from-to)1332-1341
Number of pages10
JournalNeurology
Volume81
Issue number15
DOIs
StatePublished - Oct 8 2013

Fingerprint

Chromosomes, Human, Pair 9
Open Reading Frames
Mutation
Southern Blotting
Immunohistochemistry
Polymerase Chain Reaction
Microtubule-Associated Proteins
varespladib methyl
Neurodegenerative Diseases
Chromosome
Repeats
Phenotype
Brain
Genes

ASJC Scopus subject areas

  • Clinical Neurology
  • Arts and Humanities (miscellaneous)
  • Medicine(all)

Cite this

C9ORF72 repeat expansions in cases with previously identified pathogenic mutations. / Van Blitterswijk, Marka; Baker, Matthew C.; Hernandez, Mariely; Ghidoni, Roberta; Benussi, Luisa; Finger, Elizabeth; Hsiung, Ging Yuek R; Kelley, Brendan J.; Murray, Melissa E; Rutherford, Nicola J.; Brown, Patricia E.; Ravenscroft, Thomas; Mullen, Bianca; Ash, Peter E A; Bieniek, Kevin F.; Hatanpaa, Kimmo J.; Karydas, Anna; Wood, Elisabeth McCarty; Coppola, Giovanni; Bigio, Eileen H.; Lippa, Carol; Strong, Michael J.; Beach, Thomas G.; Knopman, David S; Huey, Edward D.; Mesulam, Marsel; Bird, Thomas; White, Charles L.; Kertesz, Andrew; Geschwind, Dan H.; Van Deerlin, Vivianna M.; Petersen, Ronald Carl; Binetti, Giuliano; Miller, Bruce L.; Petrucelli, Leonard; Wszolek, Zbigniew K; Boylan, Kevin B.; Graff Radford, Neill R; MacKenzie, Ian R.; Boeve, Bradley F; Dickson, Dennis W; Rademakers, Rosa V.

In: Neurology, Vol. 81, No. 15, 08.10.2013, p. 1332-1341.

Research output: Contribution to journalArticle

Van Blitterswijk, M, Baker, MC, Hernandez, M, Ghidoni, R, Benussi, L, Finger, E, Hsiung, GYR, Kelley, BJ, Murray, ME, Rutherford, NJ, Brown, PE, Ravenscroft, T, Mullen, B, Ash, PEA, Bieniek, KF, Hatanpaa, KJ, Karydas, A, Wood, EM, Coppola, G, Bigio, EH, Lippa, C, Strong, MJ, Beach, TG, Knopman, DS, Huey, ED, Mesulam, M, Bird, T, White, CL, Kertesz, A, Geschwind, DH, Van Deerlin, VM, Petersen, RC, Binetti, G, Miller, BL, Petrucelli, L, Wszolek, ZK, Boylan, KB, Graff Radford, NR, MacKenzie, IR, Boeve, BF, Dickson, DW & Rademakers, RV 2013, 'C9ORF72 repeat expansions in cases with previously identified pathogenic mutations', Neurology, vol. 81, no. 15, pp. 1332-1341. https://doi.org/10.1212/WNL.0b013e3182a8250c
Van Blitterswijk, Marka ; Baker, Matthew C. ; Hernandez, Mariely ; Ghidoni, Roberta ; Benussi, Luisa ; Finger, Elizabeth ; Hsiung, Ging Yuek R ; Kelley, Brendan J. ; Murray, Melissa E ; Rutherford, Nicola J. ; Brown, Patricia E. ; Ravenscroft, Thomas ; Mullen, Bianca ; Ash, Peter E A ; Bieniek, Kevin F. ; Hatanpaa, Kimmo J. ; Karydas, Anna ; Wood, Elisabeth McCarty ; Coppola, Giovanni ; Bigio, Eileen H. ; Lippa, Carol ; Strong, Michael J. ; Beach, Thomas G. ; Knopman, David S ; Huey, Edward D. ; Mesulam, Marsel ; Bird, Thomas ; White, Charles L. ; Kertesz, Andrew ; Geschwind, Dan H. ; Van Deerlin, Vivianna M. ; Petersen, Ronald Carl ; Binetti, Giuliano ; Miller, Bruce L. ; Petrucelli, Leonard ; Wszolek, Zbigniew K ; Boylan, Kevin B. ; Graff Radford, Neill R ; MacKenzie, Ian R. ; Boeve, Bradley F ; Dickson, Dennis W ; Rademakers, Rosa V. / C9ORF72 repeat expansions in cases with previously identified pathogenic mutations. In: Neurology. 2013 ; Vol. 81, No. 15. pp. 1332-1341.
@article{01a1ee6f1e724a86867111e8653ddfc2,
title = "C9ORF72 repeat expansions in cases with previously identified pathogenic mutations",
abstract = "Objective: To identify potential genetic modifiers contributing to the phenotypic variability that is detected in patients with repeat expansions in chromosome 9 open reading frame 72 (C9ORF72), we investigated the frequency of these expansions in a cohort of 334 subjects previously found to carry mutations in genes known to be associated with a spectrum of neurodegenerative diseases. Methods: A 2-step protocol, with a fluorescent PCR and a repeat-primed PCR, was used to determine the presence of hexanucleotide expansions in C9ORF72. For one double mutant, we performed Southern blots to assess expansion sizes, and immunohistochemistry to characterize neuropathology. Results: We detected C9ORF72 repeat expansions in 4 of 334 subjects (1.2{\%} [or 1.8{\%} of 217 families]). All these subjects had behavioral phenotypes and also harbored well-known pathogenic mutations in either progranulin (GRN: p.C466LfsX46, p.R493X, p.C31LfsX35) or microtubule-associated protein tau (MAPT: p.P301L). Southern blotting of one double mutant with a p.C466LfsX46 GRN mutation demonstrated a long repeat expansion in brain (>3,000 repeats), and immunohistochemistry showed mixed neuropathology with characteristics of both C9ORF72 expansions and GRN mutations. Conclusions: Our findings indicate that co-occurrence of 2 evidently pathogenic mutations could contribute to the pleiotropy that is detected in patients with C9ORF72 repeat expansions. These findings suggest that patients with known mutations should not be excluded from further studies, and that genetic counselors should be aware of this phenomenon when advising patients and their family members.",
author = "{Van Blitterswijk}, Marka and Baker, {Matthew C.} and Mariely Hernandez and Roberta Ghidoni and Luisa Benussi and Elizabeth Finger and Hsiung, {Ging Yuek R} and Kelley, {Brendan J.} and Murray, {Melissa E} and Rutherford, {Nicola J.} and Brown, {Patricia E.} and Thomas Ravenscroft and Bianca Mullen and Ash, {Peter E A} and Bieniek, {Kevin F.} and Hatanpaa, {Kimmo J.} and Anna Karydas and Wood, {Elisabeth McCarty} and Giovanni Coppola and Bigio, {Eileen H.} and Carol Lippa and Strong, {Michael J.} and Beach, {Thomas G.} and Knopman, {David S} and Huey, {Edward D.} and Marsel Mesulam and Thomas Bird and White, {Charles L.} and Andrew Kertesz and Geschwind, {Dan H.} and {Van Deerlin}, {Vivianna M.} and Petersen, {Ronald Carl} and Giuliano Binetti and Miller, {Bruce L.} and Leonard Petrucelli and Wszolek, {Zbigniew K} and Boylan, {Kevin B.} and {Graff Radford}, {Neill R} and MacKenzie, {Ian R.} and Boeve, {Bradley F} and Dickson, {Dennis W} and Rademakers, {Rosa V}",
year = "2013",
month = "10",
day = "8",
doi = "10.1212/WNL.0b013e3182a8250c",
language = "English (US)",
volume = "81",
pages = "1332--1341",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "15",

}

TY - JOUR

T1 - C9ORF72 repeat expansions in cases with previously identified pathogenic mutations

AU - Van Blitterswijk, Marka

AU - Baker, Matthew C.

AU - Hernandez, Mariely

AU - Ghidoni, Roberta

AU - Benussi, Luisa

AU - Finger, Elizabeth

AU - Hsiung, Ging Yuek R

AU - Kelley, Brendan J.

AU - Murray, Melissa E

AU - Rutherford, Nicola J.

AU - Brown, Patricia E.

AU - Ravenscroft, Thomas

AU - Mullen, Bianca

AU - Ash, Peter E A

AU - Bieniek, Kevin F.

AU - Hatanpaa, Kimmo J.

AU - Karydas, Anna

AU - Wood, Elisabeth McCarty

AU - Coppola, Giovanni

AU - Bigio, Eileen H.

AU - Lippa, Carol

AU - Strong, Michael J.

AU - Beach, Thomas G.

AU - Knopman, David S

AU - Huey, Edward D.

AU - Mesulam, Marsel

AU - Bird, Thomas

AU - White, Charles L.

AU - Kertesz, Andrew

AU - Geschwind, Dan H.

AU - Van Deerlin, Vivianna M.

AU - Petersen, Ronald Carl

AU - Binetti, Giuliano

AU - Miller, Bruce L.

AU - Petrucelli, Leonard

AU - Wszolek, Zbigniew K

AU - Boylan, Kevin B.

AU - Graff Radford, Neill R

AU - MacKenzie, Ian R.

AU - Boeve, Bradley F

AU - Dickson, Dennis W

AU - Rademakers, Rosa V

PY - 2013/10/8

Y1 - 2013/10/8

N2 - Objective: To identify potential genetic modifiers contributing to the phenotypic variability that is detected in patients with repeat expansions in chromosome 9 open reading frame 72 (C9ORF72), we investigated the frequency of these expansions in a cohort of 334 subjects previously found to carry mutations in genes known to be associated with a spectrum of neurodegenerative diseases. Methods: A 2-step protocol, with a fluorescent PCR and a repeat-primed PCR, was used to determine the presence of hexanucleotide expansions in C9ORF72. For one double mutant, we performed Southern blots to assess expansion sizes, and immunohistochemistry to characterize neuropathology. Results: We detected C9ORF72 repeat expansions in 4 of 334 subjects (1.2% [or 1.8% of 217 families]). All these subjects had behavioral phenotypes and also harbored well-known pathogenic mutations in either progranulin (GRN: p.C466LfsX46, p.R493X, p.C31LfsX35) or microtubule-associated protein tau (MAPT: p.P301L). Southern blotting of one double mutant with a p.C466LfsX46 GRN mutation demonstrated a long repeat expansion in brain (>3,000 repeats), and immunohistochemistry showed mixed neuropathology with characteristics of both C9ORF72 expansions and GRN mutations. Conclusions: Our findings indicate that co-occurrence of 2 evidently pathogenic mutations could contribute to the pleiotropy that is detected in patients with C9ORF72 repeat expansions. These findings suggest that patients with known mutations should not be excluded from further studies, and that genetic counselors should be aware of this phenomenon when advising patients and their family members.

AB - Objective: To identify potential genetic modifiers contributing to the phenotypic variability that is detected in patients with repeat expansions in chromosome 9 open reading frame 72 (C9ORF72), we investigated the frequency of these expansions in a cohort of 334 subjects previously found to carry mutations in genes known to be associated with a spectrum of neurodegenerative diseases. Methods: A 2-step protocol, with a fluorescent PCR and a repeat-primed PCR, was used to determine the presence of hexanucleotide expansions in C9ORF72. For one double mutant, we performed Southern blots to assess expansion sizes, and immunohistochemistry to characterize neuropathology. Results: We detected C9ORF72 repeat expansions in 4 of 334 subjects (1.2% [or 1.8% of 217 families]). All these subjects had behavioral phenotypes and also harbored well-known pathogenic mutations in either progranulin (GRN: p.C466LfsX46, p.R493X, p.C31LfsX35) or microtubule-associated protein tau (MAPT: p.P301L). Southern blotting of one double mutant with a p.C466LfsX46 GRN mutation demonstrated a long repeat expansion in brain (>3,000 repeats), and immunohistochemistry showed mixed neuropathology with characteristics of both C9ORF72 expansions and GRN mutations. Conclusions: Our findings indicate that co-occurrence of 2 evidently pathogenic mutations could contribute to the pleiotropy that is detected in patients with C9ORF72 repeat expansions. These findings suggest that patients with known mutations should not be excluded from further studies, and that genetic counselors should be aware of this phenomenon when advising patients and their family members.

UR - http://www.scopus.com/inward/record.url?scp=84888235194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888235194&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e3182a8250c

DO - 10.1212/WNL.0b013e3182a8250c

M3 - Article

C2 - 24027057

AN - SCOPUS:84888235194

VL - 81

SP - 1332

EP - 1341

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 15

ER -